• Publications
  • Influence
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage
PURPOSE To compare the progression-free and overall survival in small-volume residual ovarian cancer after treatment with intravenous (IV) cisplatin and paclitaxel or an experimental regimen of IVExpand
  • 912
  • 23
Vascular permeability factor gene expression in normal and neoplastic human ovaries.
Epithelial ovarian cancer is an aggressive malignancy with a generally poor outcome. To improve survival, novel therapeutic strategies for this disease are needed and require elucidation of theExpand
  • 277
  • 8
  • PDF
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.
BACKGROUND Natural killer (NK) cells derived from patients with cancer exhibit diminished cytotoxicity compared with NK cells from healthy individuals. We evaluated the tumor response and in vivoExpand
  • 293
  • 8
Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.
PURPOSE Anemia during radiation therapy independently predicts poor outcome in patients with cervical cancer. Despite a randomized trial demonstrating red cell transfusions improve local control andExpand
  • 130
  • 6
Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: A prospective randomized controlled study.
INTRODUCTION Optimal pain control after major surgery contributes to a patient's recovery and satisfaction. The use of liposomal bupivacaine in subcostal transversus abdominis plane (TAP) blocks forExpand
  • 55
  • 5
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer.
OBJECTIVE To determine feasibility and efficacy of administering docetaxel and carboplatin chemotherapy followed by pelvic radiotherapy and then consolidation chemotherapy in patients with advancedExpand
  • 41
  • 5
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
OBJECTIVES To determine progression-free survival (PFS) and overall survival (OS) in women with completely resected stage I or II carcinosarcoma of the uterus treated with adjuvant ifosfamide andExpand
  • 108
  • 4
Differential expression of the cell‐cell adhesion molecule E‐cadherin in ascites and solid human ovarian tumor cells
Advanced ovarian cancers contain 2 distinct phenotypic populations: (a) free‐floating tumor cells in the ascitic fluid and (b) solid tumors. Ascites cells are derived from the solid tumors and spreadExpand
  • 126
  • 4
A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy.
OBJECTIVES Based on the reduced morbidity seen in our retrospective study, we undertook a prospective, randomized trial to determine whether transposition of the sartorius muscle improvesExpand
  • 71
  • 4
Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer.
OBJECTIVES Studies in several solid tumors have shown that the presence of occult metastasis in the bone marrow or peripheral blood is highly predictive of decreased disease-free and overallExpand
  • 63
  • 4